Plain-English translation of NCT04879329 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
Phase 2 — Testing in a bigger group (up to a few hundred people) to see if the treatment actually works and is still safe.
This study is testing a new drug called to treat advanced bladder cancer that cannot be surgically removed or has spread throughout the body. Researchers want to see how well this medication works—either on its own or combined with another drug called —and what side effects patients may experience. The study will enroll about 372 people across multiple locations.
Bladder cancer that has spread or cannot be removed surgically is very difficult to treat, and current options don't work well for everyone. This trial is investigating whether this new treatment approach can give patients with this aggressive form of cancer better outcomes and more choices.
You likely qualify if…
You likely don't qualify if…
Participants will receive intravenous infusions of the medication at regular clinic visits, either alone or combined with another drug, depending on which study group they are assigned to. You'll have blood tests, imaging scans, and regular check-ins with the study team to monitor how you're responding and track any side effects. The study will continue until your cancer progresses, you experience unacceptable side effects, or the research team determines the treatment isn't working for you.
AI-generated summary from trial data · Jun 7, 2026 · Not medical advice
United States